Navigation Links
MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks
Date:11/12/2008

HORSHAM, Pa., Nov. 12 /PRNewswire/ -- Centocor, Inc. announced today the launch of MEDVERSATION(TM) (http://www.medversation.com), an extensive web-based resource designed to facilitate more-informed conversations between U.S. physicians and their patients about the efficacy and safety of REMICADE(R) (infliximab).

This interactive web application, in development for the past three years and the first in its therapeutic class, provides physicians general information about the progression of certain inflammatory diseases. In addition, physicians can access detailed summaries of REMICADE clinical data and interactive tools to manage and customize information for discussions with patients.

"We recognize that health care conversations have become increasingly complex over the past few years, with physicians being faced with an escalating volume of information about drug benefits and risks from numerous sources," said Thomas Schaible, Vice President, Medical Affairs, Centocor, Inc. "We hope MEDVERSATION will play a role in helping physicians access information on disease states and clinical data about REMICADE, to enable them to more readily participate in dialogue with an increasingly more informed and empowered patient population. We want all patients to receive treatment that it is right for them, regardless of whether or not the treatment may be ours."

Centocor created MEDVERSATION with the belief that informed conversations between health care professionals and patients diagnosed with serious inflammatory diseases are essential to quality care. To that end, Centocor has attempted to construct a useful resource for physicians to consider the multiple dimensions of individual medical decisions that involve our therapies now and in the future.

Content within MEDVERSATION is organized into four main sections, paralleling the core dimensions of a medical conversation:


'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. AARP Launches New Fitness Website for AARP Members - AARPfitness.com
2. New Website Helps Women Be Fit, Sexy and in Control!
3. Top Twenty Health Plan Websites Named by TheRatingsGuy.com
4. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
5. New Website Launches Healthy Vending in Schools Nationwide to Help Combat Childhood Obesity
6. Walgreens Launches New Health Essentials Catalog and Website for AARP Members Featuring More Than 20,000 Health-Related Products
7. The Joint Commission Enhances Quality Check Website
8. China Medical Technologies to Post 2006 Annual Report on Its Website
9. Suicide Prevention Organization Launches New Website
10. ABR -- Affinity BioReagents Announces Launch of New Website
11. New Website Contributes to Healthy Workplace Culture
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:U.S. Healthcare Efficiency Index(TM) Expands Advisory Council; Calls on Policymakers to Act on Billions in Administrative Waste 2Health News:U.S. Healthcare Efficiency Index(TM) Expands Advisory Council; Calls on Policymakers to Act on Billions in Administrative Waste 3Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 2Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 3Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 4Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 5Health News:Seniors' Website Publishers Ask President to Curtail FDA Seizures of Vital Medicines 2Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 2Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 3Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 4Health News:Evil-doers everywhere: Get a whiff of this 2Health News:Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain 2Health News:Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain 3
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4Diageos DRINKiQ com Honored as Most Outstanding Health 26 Wellness Site by International Academy of the Visual Arts 51004 1Diageos DRINKiQ com Honored as Most Outstanding Health 26 Wellness Site by International Academy of the Visual Arts 51004 2Diageos DRINKiQ com Honored as Most Outstanding Health 26 Wellness Site by International Academy of the Visual Arts 51004 3KePRO Names Two New Business Development Directors 51002 1KePRO Names Two New Business Development Directors 51002 2AMB Property Corporation 28R 29 Leases 440 000 SF in Hamburg 51000 1AMB Property Corporation 28R 29 Leases 440 000 SF in Hamburg 51000 2AMB Property Corporation 28R 29 Leases 440 000 SF in Hamburg 51000 3AMB Property Corporation 28R 29 Leases 440 000 SF in Hamburg 51000 4